NLRP3 Blockade Suppresses Pro-Inflammatory and Pro-Angiogenic Cytokine Secretion in Diabetic Retinopathy

References

• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
   PubMed Web of Science ®Google Scholar
• Alves BC, Silva TR, Spritzer PM, Lifestyle S. High-carbohydrate intake are associated with low-grade chronic inflammation in post-menopause: a cross-sectional study. Rev Bras Ginecol Obstet. 2016;38(7):317–324. doi:10.1055/s-0036-1584582
   PubMedGoogle Scholar
• Rubsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol Sci. 2018;19(4):942. doi:10.3390/ijms19040942
   PubMed Web of Science ®Google Scholar
• Cai M, Zhang X, Li Y, et al. Toll-like receptor 3 activation drives the inflammatory response in oxygen-induced retinopathy in rats. Br J Ophthalmol. 2015;99(1):125–132. doi:10.1136/bjophthalmol-2014-305690
   PubMedGoogle Scholar
• Liu X, Zhang Z, Ruan J, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535(7610):153–158. doi:10.1038/nature18629
   PubMed Web of Science ®Google Scholar
• Feng H, Gu J, Gou F, et al. High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP pathway in mesangial cells. J Diabetes Res. 2016;2016:6973175. doi:10.1155/2016/6973175
   PubMed Web of Science ®Google Scholar
• Zhong Z, Umemura A, Sanchez-Lopez E, et al. NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria. Cell. 2016;164(5):896–910. doi:10.1016/j.cell.2015.12.057
   PubMed Web of Science ®Google Scholar
• Tartey S, Kanneganti TD. Differential role of the NLRP3 inflammasome in infection and tumorigenesis. Immunology. 2019;156(4):329–338. doi:10.1111/imm.13046
   PubMedGoogle Scholar
• Malhotra S, Costa C, Eixarch H, et al. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain. 2020;143(5):1414–1430. doi:10.1093/brain/awaa084
   PubMedGoogle Scholar
• Minutoli L, Puzzolo D, Rinaldi M, et al. ROS-Mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxid Med Cell Longev. 2016;2016:2183026. doi:10.1155/2016/2183026
   PubMed Web of Science ®Google Scholar
• Chi W, Chen H, Li F, et al. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-kappaB pathway in acute glaucoma. J Neuroinflammation. 2015;12:137. doi:10.1186/s12974-015-0360-2
   PubMed Web of Science ®Google Scholar
• Park B, Jo K, Lee TG, et al. Polydatin Inhibits NLRP3 inflammasome in dry eye disease by attenuating oxidative stress and inhibiting the NF-kappaB pathway. Nutrients. 2019;11:(11)2792. doi:10.3390/nu11112792
   Google Scholar
• Sun HJ, Jin XM, Xu J, et al. Baicalin alleviates age-related macular degeneration via miR-223/NLRP3-regulated pyroptosis. Pharmacology. 2020;105(1–2):28–38. doi:10.1159/000502614
   PubMed Web of Science ®Google Scholar
• Chaurasia SS, Lim RR, Parikh BH, et al. The NLRP3 inflammasome may contribute to pathologic neovascularization in the advanced stages of diabetic retinopathy. Sci Rep. 2018;8(1):2847. doi:10.1038/s41598-018-21198-z
   PubMed Web of Science ®Google Scholar
• Shi H, Zhang Z, Wang X, et al. Inhibition of autophagy induces IL-1β release from ARPE-19 cells via ROS mediated NLRP3 inflammasome activation under high glucose stress. Biochem Biophys Res Commun. 2015;463(4):1071–1076. doi:10.1016/j.bbrc.2015.06.060
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu L, Curtiss E, et al. Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1beta in retinal endothelial cells and mouse retinal vasculature. Mediators Inflamm. 2017;2017:2860956. doi:10.1155/2017/2860956
   PubMed Web of Science ®Google Scholar
• Jiang S, Chen X. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Drug Des Devel Ther. 2017;11:783–795. doi:10.2147/DDDT.S129913
   PubMed Web of Science ®Google Scholar
• Wu J, Ke X, Fu W, et al. Inhibition of hypoxia-induced retinal angiogenesis by specnuezhenide, an effective constituent of ligustrum lucidum ait., through suppression of the HIF-1alpha/VEGF signaling pathway. Molecules. 2016;21(12). doi:10.3390/molecules21121756
   Web of Science ®Google Scholar
• Zhang Y, Lv X, Hu Z, et al. Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction. Cell Death Dis. 2017;8(7):e2941. doi:10.1038/cddis.2017.308
   PubMedGoogle Scholar
• Liu Q, Zhang F, Zhang X, et al. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Mol Cell Biochem. 2018;445(1–2):105–115. doi:10.1007/s11010-017-3256-x
   PubMed Web of Science ®Google Scholar
• Li S, Yang H, Chen X. Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation. Exp Anim. 2019;68(2):221–231. doi:10.1538/expanim.18-0146
   PubMed Web of Science ®Google Scholar
• Hu L, Yang H, Ai M, et al. Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose. Graefes Arch Clin Exp Ophthalmol. 2017;255(11):2199–2210. doi:10.1007/s00417-017-3772-0
   PubMedGoogle Scholar
• Sun J, Liao W, Su K, et al. Suberoylanilide hydroxamic acid attenuates interleukin-1beta-induced interleukin-6 upregulation by inhibiting the microtubule affinity-regulating kinase 4/nuclear Factor-kappaB pathway in synovium-derived mesenchymal stem cells from the temporomandibular joint. Inflammation. 2020. doi:10.1007/s10753-020-01204-1
   Google Scholar
• Cheng SC, Huang WC, SP JH, et al. Quercetin Inhibits the Production of IL-1beta-induced inflammatory cytokines and chemokines in ARPE-19 Cells via the MAPK and NF-kappaB signaling pathways. Int J Mol Sci. 2019;20:12. doi:10.3390/ijms20122957
   Google Scholar
• Wang S, Ji L-Y, Li L, et al. Oxidative stress, autophagy and pyroptosis in the neovascularization of oxygen‑induced retinopathy in mice. Mol Med Rep. 2019;19(2):927–934. doi:10.3892/mmr.2018.9759
   PubMed Web of Science ®Google Scholar
• Doktor F, Prager P, Wiedemann P, et al. Hypoxic expression of NLRP3 and VEGF in cultured retinal pigment epithelial cells: contribution of P2Y2 receptor signaling. Purinergic Signal. 2018;14(4):471–484. doi:10.1007/s11302-018-9631-6
   PubMedGoogle Scholar
• Sui A, Zhong Y, Demetriades AM, et al. Inhibition of integrin alpha5beta1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model. Graefes Arch Clin Exp Ophthalmol. 2018;256(5):951–961. doi:10.1007/s00417-018-3940-x
   PubMed Web of Science ®Google Scholar
• Ayalasomayajula SP, Kompella UB. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur J Pharmacol. 2003;458(3):283–289. doi:10.1016/s0014-2999(02)02793-0
   PubMedGoogle Scholar
• Xu XH, Zhao C, Peng Q, et al. Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment. Braz J Med Biol Res. 2017;50(3):e5396. doi:10.1590/1414-431X20165396
   PubMed Web of Science ®Google Scholar
• Zhang D, Lv FL, Wang GH. Effects of HIF-1alpha on diabetic retinopathy angiogenesis and VEGF expression. Eur Rev Med Pharmacol Sci. 2018;22(16):5071–5076. doi:10.26355/eurrev_201808_15699
   PubMedGoogle Scholar
• Gao X, Li Y, Wang H, et al. Inhibition of HIF-1alpha decreases expression of pro-inflammatory IL-6 and TNF-alpha in diabetic retinopathy. Acta Ophthalmol. 2017;95(8):e746–e50. doi:10.1111/aos.13096
   PubMedGoogle Scholar